Andelyn Biosciences uses AAV curator platform to deliver novel gene therapy for ultra-rare NEDAMSS disease Read more
Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space: GlobalData Read more
CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData Read more